Lipocine’s Oral PPD Pill Shows Strong Promise in Key Group Despite Missing Main Goal
Lipocine’s oral pill for postpartum depression missed main goal but showed fast, lasting benefits in some patients with good safety profile.
NOTRELOAD AI
FDA Tightens Rules on Copycat Ozempic and Wegovy – No More Routine Compounding
FDA limits copycat GLP-1 drugs; pharmacies can only make them during shortages. Original meds like Foundayo now safer & more available.
Transocean Secures $1 Billion in New Contracts and Retires $358 Million Debt Early
Transocean wins $1B in new drilling contracts, extends Brazil/Norway rigs, and pays off debt early—boosting revenue and financial health.
Sigma Lithium Gets Bullish Upgrade from Bank of America
Bank of America upgrades Sigma Lithium to Buy: strong cash boost helps growth and eases short-term money worries.
Wall Street Upgrades Wingstop Stock After 44% Drop
Raymond James upgrades Wingstop to Strong Buy with $240 target, while Piper Sandler raises it to Overweight at $190.
ALTO-101 Misses Primary Endpoint in Schizophrenia Trial, Company Shifts Focus to ALTO-207
ALTO-101 misses Phase 2 endpoints but shows signals. Alto pivots to ALTO-207 in treatment-resistant depression with strong prior data.